# News and Insights

> News and insights from Golden Triangle Consultants on pharmaceutical pricing, market access, IRP, HTA and AI.

Canonical: https://goldentriangleconsultants.com/news-and-insights/

Date: 18 September 2026

## [US MFN Drug Pricing: What Changed Between 2025 and 2026?](https://goldentriangleconsultants.com/news-and-insights/f/us-mfn-drug-pricing-2025-2026/)

US MFN pricing has moved from political ambition to deals and draft rules. What has changed, why Medicare timelines look uncertain, and what to model next.

Date: 24 February 2026

## [Golden Triangle Consultants at World EPA Congress 2026](https://goldentriangleconsultants.com/news-and-insights/f/golden-triangle-consultants-at-world-epa-2026/)

Golden Triangle Consultants will attend the World Evidence, Pricing and Access Congress 2026 in Amsterdam on 3–4 March.

Date: 23 July 2025

## [Could US Reboot Signal the Value Based Pricing Tipping Point?](https://goldentriangleconsultants.com/news-and-insights/f/could-us-reboot-signal-the-value-based-pricing-tipping-point/)

Value-based pricing may be entering a new phase as high-cost advanced therapies, outcomes-based agreements and changing evidence capabilities challenge traditional pricing models.

Date: 15 July 2025

## [Saudi HTA July 2025: Gulf & Global Pricing Implications](https://goldentriangleconsultants.com/news-and-insights/f/saudi-hta-july-2025-gulf-global-pricing-implications/)

Saudi Arabia’s move towards mandatory economic evaluation adds a value-based layer to a market already influential through IRP and Gulf procurement.

Date: 2 July 2025

## [Canada Finalises PMPRB Drug Pricing Rules: Key Takeaways](https://goldentriangleconsultants.com/news-and-insights/f/canada-finalises-pmprb-drug-pricing-rules-key-takeaways/)

Canada’s PMPRB published its updated Guidelines in June 2025, marking a significant shift in how staff identify patented medicines for potential excessive-price review.

Date: 22 May 2025

## [Global Ripple Effects of the U.S. “MFN” Pricing Order](https://goldentriangleconsultants.com/news-and-insights/f/global-ripple-effects-of-the-us-mfn-pricing-order/)

The May 2025 US Most-Favoured-Nation drug-pricing order has implications that extend into global launch sequencing, list-price strategy and international reference pricing.

Date: 14 April 2025

## [EU HTA Goes Live: What the JCA Means for Access, Pricing & IRP](https://goldentriangleconsultants.com/news-and-insights/f/eu-hta-goes-live-what-the-jca-means-for-access-pricing-irp/)

The EU HTA Regulation began applying in January 2025, introducing Joint Clinical Assessments for oncology medicines and advanced therapies and changing evidence planning across Europe.

Date: 30 January 2025

## [Bracing for 22.9%: What the 2025 VPAG Payback Rate Means](https://goldentriangleconsultants.com/news-and-insights/f/bracing-for-229-what-the-2025-vpag-payback-rate-means/)

The 2025 VPAG headline payment percentage for eligible newer medicines was set at 22.9%, creating significant forecasting and UK launch-strategy considerations.

Date: 5 March 2024

## [GTC Returns to EPA](https://goldentriangleconsultants.com/news-and-insights/f/gtc-returns-to-epa/)

Golden Triangle Consultants returned to the World Evidence, Pricing and Access Congress in Amsterdam in 2024.

Date: 20 April 2023

## [AI vs. Health Economists: Can ChatGPT Build Budget Impact Models?](https://goldentriangleconsultants.com/news-and-insights/f/ai-vs-health-economists-can-chat-gpt-build-budget-impact-models/)

An early practical experiment testing whether ChatGPT could guide the construction of a simple pharmaceutical budget impact model in Excel.

Date: 5 April 2023

## [AI-Generated Content in Pharmaceuticals: A Cautionary Tale](https://goldentriangleconsultants.com/news-and-insights/f/ai-generated-content-in-pharmaceuticals-a-cautionary-tale/)

An early experiment with generative AI highlighted both the impressive fluency of AI-generated pharmaceutical content and the serious risk of fabricated evidence and references.

Date: 15 March 2023

## [Golden Triangle Consultants at EPA 2023](https://goldentriangleconsultants.com/news-and-insights/f/golden-triangle-consultants-at-epa-2023/)

Golden Triangle Consultants attended the World Evidence, Pricing and Access Congress 2023 in Amsterdam.